摘要
目的探讨Vav3基因在胃癌多药耐药性(MDR)中的作用及可能机制。方法采用荧光定量反转录聚合酶链(QRT-PCR)及蛋白印迹技术检测Vav3在胃癌、癌旁组织及人胃癌细胞株SGC7901、胃上皮细胞GES-1中的表达;合成针对Vav3的siRNA,并转染SGC7901;MTT法检测氟尿嘧啶(5-FU)、奥沙利铂(L-OHP)对转染前后胃癌细胞的抑制率;荧光定量RT-PCR和蛋白质印迹法检测转染前后凋亡抑制蛋白家族成员xIAP、Survivin、Livin表达,并检测Caspase-3、Caspase-8表达及活性。结果 Vav3在胃癌组织及细胞株的表达高于癌旁组织及胃上皮细胞株(P<0.05);Vav3-siRNA转染SGC7901后Vav3表达明显受到抑制(P<0.01);Vav3-siRNA转染SGC7901 48h后5-FU、L-OHP对肿瘤细胞的抑制作用均明显增强(P<0.05);转染后SGC7901中xIAP、Survivin的表达均较转染前降低(P<0.05),Livin表达在转染前后无明显变化;转染后Caspase-3、Caspase-8表达及活性升高(P<0.05)。结论 Vav3可通过调控胃癌细胞凋亡抑制途径参与胃癌多药耐药,抑制Vav3表达可能有助于逆转胃癌细胞的化疗耐药。
Objective To explore the role of Vav3 gene in multidrug resistance(MDR)of gastric cancer and the related mechanism.Methods QRT-PCR was used to examine the expressions of Vav3 gene in gastric cancer tissues,tumor-adjacent tissues,human gastric cancer cell line SGC7901,and gastric epithelial cell line GES-1.Then Vav3-siRNA was synthesized and tansfected into SGC7901 cells. MTT assay was then used to determine the inhibition rates of tumor cells exposed to chemotherapeutic agents(5-FU,L-OHP)before and after Vav3-siRNA transfection.Real-time RT-PCR and Western blotting analysis were used to observe the expressions of inhibitor of apoptosis proteins(IAPs):xIAP,Survivin,and Livin;meanwhile,the expression and activity of Caspase-3and Caspase-8 were also determined.Results Vav3 was over-expressed in gastric cancer tissues and gastric cell line compared with those in tumor-adjacent tissues and gastric epithelial cell line GES-1(P<0.05).Expression of Vav3 was significantly inhibited by Vav3-siRNA(P<0.01).Inhibition rates of tumor cells exposed to 5-FU and L-OHP were significantly increased 48 hafter Vav3-siRNA tansfection(P<0.05).The expressions of xIAP and Survivin were significantly decreased in cancer cells after Vav3-siRNA tansfection(both P<0.05),and no notable change was found for Livin expression;also the expression and activity of Caspase-3and Caspase-8protein were significantly increased after Vav3-siRNA tansfection in SGC7901cells(all P<0.05).Conclusion Vav3 can participate in MDR of gastric cancer by regulating apoptotic pathways,and inhibition of Vav3 can help reverse MDR of gastric cancer cells by regulating some IAPs.
引文
[1]Zhu C Y,Lv Y P,Yan D F,Gao F L.Knockdown of MDR1increases the sensitivity to adriamycin in drug resistant gastric cancer cells[J].Asian Pac J Cancer Prev,2013,14:6757-6760.
[2]Yan L H,Wang X T,Yang J,Kong F B,Lian C,Wei W Y,et al.Reversal of multidrug resistance in gastric cancer cells by E2F-1downregulation in vitro and in vivo[J].J Cell Biochem,2014,115:34-41.
[3]Xie X,Tang B,Zhou J,Gao Q,Zhang P.Inhibition of the PI3K/Akt pathway increases the chemosensitivity of gastric cancer to vincristine[J].Oncol Rep,2013,30:773-782.
[4]檀碧波,李勇,范立侨,赵群,刘羽,赵雪峰.胃癌凋亡相关蛋白Survivin、B淋巴细胞/白血病-2、bax表达与肿瘤细胞体外化疗药敏性的关系[J].中华实验外科杂志,2012,29:1315-1317.
[5]Li Y,Tan B B,Zhao Q,Fan L Q,Liu Y,Hao Y J,et al.Tumor chemosensitivity is correlated with expression of multidrug resistance associated factors in variously differentiated gastric carcinoma tissues[J].Hepatogastroenterology,2013,60:213-216.
[6]Gazzaniga P,Gradilone A,Petracca A,Nicolazzo C,Raimondi C,Iacovelli R,et al.Molecular markers in circulating tumour cells from metastatic colorectal cancer patients[J].J Cell Mol Med,2010,14:2073-2077.
[7]Fernandez-Salguero P M.A remarkable new target gene for the dioxin receptor:the Vav3proto-oncogene links AhR to adhesion and migration[J].Cell Adh Migr,2010,4:172-175.
[8]Chang K H,Sanchez-Aguilera A,Shen S,Sengupta A,Madhu M N,Ficker A M,et al.Vav3collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis,proliferation,and survival[J].Blood,2012,120:800-811.
[9]Nomura T,Yamasaki M,Hirai K,Inoue T,Sato R,Matsuura K,et al.Targeting the Vav3oncogene enhances docetaxel-induced apoptosis through the inhibition of androgen receptor phosphorylation in LNCaP prostate cancer cells under chronic hypoxia[J].Mol Cancer,2013,12:27.
[10]Lee K,Liu Y,Mo J Q,Zhang J,Dong Z,Lu S.Vav3oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer[J].BMC Cancer,2008,8:158.
[11]Kang J,Zhao G,Lin T,Tang S,Xu G,Hu S,et al.A peptide derived from phage display library exhibits antitumor activity by targeting GRP78in gastric cancer multidrug resistance cells[J].Cancer Lett,2013,339:247-259.
[12]Wang Y,Liu L,Liu X,Zhang H,Liu J,Feng B,et al.Shugoshin1enhances multidrug resistance of gastric cancer cells by regulating MRP1,Bcl-2,and Baxgenes[J].Tumour Biol,2013,34:2205-2214.
[13]Liu Y,Wu X,Dong Z,Lu S.The molecular mechanism of Vav3oncogene on upregulation of androgen receptor activity in prostate cancer cells[J].Int J Oncol,2010,36:623-633.
[14]Travert M,Huang Y,de Leval L,Martin-Garcia N,Delfau-Larue M H,Berger F,et al.Molecular features of hepatosplenic T-cell lymphoma unravels potential novel therapeutic targets[J].Blood,2012,119:5795-5806.
[15]Chen X,Wang T,Yang D,Wang J,Li X,He Z,et al.Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients[J].Oncol Lett,2013,5:1278-1284.
[16]Wittkopf N,Günther C,Martini E,He G,Amann K,He Y W,et al.Cellular FLICE-like inhibitory protein secures intestinal epithelial cell survival and immune homeostasis by regulating caspase-8[J].Gastroenterology,2013,145:1369-1379.
[17]Sikdar S,Mukherjee A,Ghosh S,Khuda-Bukhsh A R.Condurango glycoside-rich components stimulate DNA damage-induced cell cycle arrest and ROS-mediated caspase-3 dependent apoptosis through inhibition of cell-proliferation in lung cancer,in vitro and in vivo[J].Environ Toxicol Pharmacol,2013,37:300-314.